What is the current annual EBITDA of SNY?

As of today, SNY annual EBITDA is $19.29B

What is 1-year change in SNY annual EBITDA?

SNY annual EBITDA is up +35.77% year-over-year

What is 3-year change in SNY annual EBITDA?

SNY annual EBITDA is up +33.69% over the past 3 years

How far is SNY annual EBITDA from its all-time high?

SNY annual EBITDA is currently at its all-time high

How does SNY annual EBITDA rank versus sector peers?

SNY annual EBITDA is higher than 99.32% of companies in Healthcare sector

When is SNY next annual earnings release?

As of today, the next annual earnings release for SNY has not been scheduled

What is the current quarterly EBITDA of SNY?

As of today, SNY quarterly EBITDA is $5.16B

What is SNY quarterly EBITDA most recent change?

SNY quarterly EBITDA was up +95.83% on September 30, 2022

What is 1-year change in SNY quarterly EBITDA?

SNY quarterly EBITDA is up +70.32% year-over-year

How far is SNY quarterly EBITDA from its all-time high?

SNY quarterly EBITDA is currently -20.84% below its historical high of $6.52B set on September 30, 2004

How does SNY quarterly EBITDA rank versus sector peers?

SNY quarterly EBITDA is higher than 99.45% of companies in Healthcare sector

When is SNY next earnings release?

The next earnings release for SNY is on April 23, 2026

What is the current TTM EBITDA of SNY?

As of today, SNY TTM EBITDA is $10.83B

What is SNY TTM EBITDA most recent change?

SNY TTM EBITDA was up +91.09% on September 30, 2022

What is 1-year change in SNY TTM EBITDA?

SNY TTM EBITDA is up +257.29% year-over-year

How far is SNY TTM EBITDA from its all-time high?

SNY TTM EBITDA is currently at its all-time high

How does SNY TTM EBITDA rank versus sector peers?

SNY TTM EBITDA is higher than 98.45% of companies in Healthcare sector

When is SNY next earnings release?

The next earnings release for SNY is on April 23, 2026

Sanofi (SNY) EBITDA History & Chart Since 1998

Annual EBITDA

$19.29B$5.08B+35.77%

December 31, 2025

Summary

Current Value: As of today, SNY annual EBITDA is $19.29B, up +35.77% on December 31, 2025
Historical Performance: SNY annual EBITDA is up +33.69% over the past 3 years, up +60.55% over the past 5 years
All-Time High Comparison: SNY annual EBITDA is currently at its all-time high
3-Year Low Comparison: SNY annual EBITDA is +45.47% above its 3-year low of $13.26B reached on December 31, 2023
Sector Comparison: SNY annual EBITDA is higher than 99.32% of companies in Healthcare sector

EBITDA Chart

Add series to chart

Add series to chart1/6

Performance

SNY Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$19.29B	+35.8%	+33.7%	+60.5%	+31.1%
Quarterly EBITDA	Sep 30, 22	$5.16B	+70.3%	+70.3%	+70.3%	+123.8%
TTM EBITDA	Sep 30, 22	$10.83B	+257.3%	+257.3%	+257.3%	+61.3%
Price	Mar 11, 26	$43.94	-25.2%	-7.1%	-8.2%	+27.3%
PE Ratio	Mar 11, 26	20.87	-25.2%	-7.1%	–	-86.6%
Annual Revenue	Dec 31, 25	$49.24B	+10.8%	+8.9%	+19.8%	+14.9%
Annual EPS	Dec 31, 25	$2.40	+0.1%	-31.6%	-56.9%	-13.4%
Annual EBIT	Dec 31, 25	$16.08B	+56.4%	+52.6%	+94.1%	+88.4%
Annual Net Income	Dec 31, 25	$5.62B	-6.5%	-37.0%	-60.0%	-25.8%

EBITDA Highs

SNY Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$19.29B	Dec 31, 25	at high
5Y	$19.29B	Dec 31, 25	at high
All	$19.29B	Dec 31, 25	at high

EBITDA Lows

SNY Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$13.26B	Dec 31, 23	+45.5%
5Y	$12.02B	N/A	+60.5%
All	-$3.83B	Dec 1, 98	+603.6%

EBITDA History

Year	Value	Change
2025	$19.29B	+35.8%
2024	$14.21B	+7.1%
2023	$13.26B	-8.1%
2022	$14.43B	+3.5%
2021	$13.95B	+16.1%
2020	$12.02B	+9.3%
2019	$10.99B	+9.1%
2018	$10.08B	-2.5%
2017	$10.34B	-3.8%
2016	$10.75B	-7.5%
2015	$11.63B	-12.2%
2014	$13.25B	+1.6%
2013	$13.04B	-10.3%
2012	$14.54B	-1.4%

Year	Value	Change
2011	$14.75B	+0.2%
2010	$14.71B	+5.6%
2009	$13.93B	+5.4%
2008	$13.21B	+7.6%
2007	$12.28B	+6.2%
2006	$11.56B	+13.2%
2005	$10.22B	+114.7%
2004	$4.76B	+37.2%
2003	$3.47B	+37.5%
2002	$2.52B	+32.3%
2001	$1.91B	+17.2%
2000	$1.63B	+26.6%
1999	$1.28B	+133.5%
1998	-$3.83B	-

FAQ

What is the current annual EBITDA of SNY?
As of today, SNY annual EBITDA is $19.29B
What is 1-year change in SNY annual EBITDA?
SNY annual EBITDA is up +35.77% year-over-year
What is 3-year change in SNY annual EBITDA?
SNY annual EBITDA is up +33.69% over the past 3 years
How far is SNY annual EBITDA from its all-time high?
SNY annual EBITDA is currently at its all-time high
How does SNY annual EBITDA rank versus sector peers?
SNY annual EBITDA is higher than 99.32% of companies in Healthcare sector
When is SNY next annual earnings release?
As of today, the next annual earnings release for SNY has not been scheduled

Quarterly EBITDA

$5.16B$2.53B+95.83%

September 30, 2022

Summary

Current Value: As of today, SNY quarterly EBITDA is $5.16B, up +95.83% on September 30, 2022
Historical Performance: SNY quarterly EBITDA is up +70.32% year-over-year, up +70.32% over the past 3 years
All-Time High Comparison: SNY quarterly EBITDA is currently -20.84% below its historical high of $6.52B set on September 30, 2004
3-Year Low Comparison: SNY quarterly EBITDA is at its 3-year low
Sector Comparison: SNY quarterly EBITDA is higher than 99.45% of companies in Healthcare sector

Performance

SNY Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Sep 30, 22	$5.16B	+95.8%	+70.3%	+70.3%	+70.3%
Annual EBITDA	Dec 31, 25	$19.29B	–	+35.8%	+33.7%	+60.5%
TTM EBITDA	Sep 30, 22	$10.83B	+91.1%	+257.3%	+257.3%	+257.3%
Price	Mar 11, 26	$43.94	-10.1%	-25.2%	-7.1%	-8.2%
PE Ratio	Mar 11, 26	20.87	-10.1%	-25.2%	-7.1%	–
Quarterly Revenue	Sep 30, 22	$13.14B	+22.3%	+30.7%	+30.7%	+30.7%
Quarterly EPS	Sep 30, 22	$0.83	+76.6%	+3.1%	+3.1%	+3.1%
Quarterly EBIT	Sep 30, 22	$2.78B	+90.7%	+15.3%	+15.3%	+15.3%
Quarterly Net Income	Sep 30, 22	$2.08B	+76.7%	+3.3%	+3.3%	+3.3%

Quarterly EBITDA Highs

SNY Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$5.16B	N/A	at high
3Y	$5.16B	N/A	at high
5Y	$5.16B	Sep 30, 22	at high
All	$6.52B	Sep 30, 04	-20.8%

Quarterly EBITDA Lows

SNY Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$5.16B	N/A	at low
3Y	$5.16B	N/A	at low
5Y	$2.07B	N/A	+149.4%
All	-$21.72B	Dec 31, 07	+123.8%

Quarterly EBITDA History

Month	Value	Change
Sep 2022	$5.16B	+95.8%
Jun 2022	$2.64B	-13.0%
Mar 2022	$3.03B	+46.4%
Mar 2015	$2.07B	-10.1%
Dec 2014	$2.30B	+8.5%
Dec 2013	$2.12B	-31.5%
Sep 2013	$3.10B	+4.2%
Mar 2013	$2.97B	-6.5%
Jun 2012	$3.18B	+95.6%
Jun 2011	$1.63B	-29.7%
Dec 2010	$2.31B	-38.1%
Dec 2009	$3.74B	+25.6%
Jun 2009	$2.98B	+370.9%
Dec 2008	$632.11M	-83.4%
Jun 2008	$3.82B	+117.6%
Dec 2007	-$21.72B	-724.1%
Jun 2007	$3.48B	+116.7%
Dec 2006	-$20.78B	-889.3%

Month	Value	Change
Jun 2006	$2.63B	-50.3%
Mar 2006	$5.30B	+256.6%
Dec 2005	-$3.38B	-160.9%
Sep 2005	$5.55B	+83.5%
Jun 2005	$3.02B	-42.9%
Mar 2005	$5.30B	+166.5%
Dec 2004	-$7.96B	-222.1%
Sep 2004	$6.52B	+578.3%
Jun 2004	$961.72M	-65.4%
Mar 2004	$2.78B	+173.1%
Dec 2003	-$3.81B	-239.9%
Sep 2003	$2.72B	+228.0%
Jun 2003	$829.44M	-60.3%
Mar 2003	$2.09B	+170.6%
Dec 2002	-$2.96B	-260.7%
Sep 2002	$1.84B	+210.2%
Jun 2002	$593.09M	-

FAQ

What is the current quarterly EBITDA of SNY?
As of today, SNY quarterly EBITDA is $5.16B
What is SNY quarterly EBITDA most recent change?
SNY quarterly EBITDA was up +95.83% on September 30, 2022
What is 1-year change in SNY quarterly EBITDA?
SNY quarterly EBITDA is up +70.32% year-over-year
How far is SNY quarterly EBITDA from its all-time high?
SNY quarterly EBITDA is currently -20.84% below its historical high of $6.52B set on September 30, 2004
How does SNY quarterly EBITDA rank versus sector peers?
SNY quarterly EBITDA is higher than 99.45% of companies in Healthcare sector
When is SNY next earnings release?
The next earnings release for SNY is on April 23, 2026

TTM EBITDA

$10.83B$5.16B+91.09%

September 30, 2022

Summary

Current Value: As of today, SNY TTM EBITDA is $10.83B, up +91.09% on September 30, 2022
Historical Performance: SNY TTM EBITDA is up +257.29% year-over-year, up +257.29% over the past 3 years
All-Time High Comparison: SNY TTM EBITDA is currently at its all-time high
3-Year Low Comparison: SNY TTM EBITDA is at its 3-year low
Sector Comparison: SNY TTM EBITDA is higher than 98.45% of companies in Healthcare sector

Performance

SNY Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Sep 30, 22	$10.83B	+91.1%	+257.3%	+257.3%	+257.3%
Annual EBITDA	Dec 31, 25	$19.29B	–	+35.8%	+33.7%	+60.5%
Quarterly EBITDA	Sep 30, 22	$5.16B	+95.8%	+70.3%	+70.3%	+70.3%
Price	Mar 11, 26	$43.94	-10.1%	-25.2%	-7.1%	-8.2%
PE Ratio	Mar 11, 26	20.87	-10.1%	-25.2%	-7.1%	–
TTM Revenue	Sep 30, 22	$33.93B	+63.2%	+237.5%	+237.5%	+237.5%
TTM EPS	Sep 30, 22	$2.11	+65.1%	+161.5%	+161.5%	+161.5%
TTM EBIT	Sep 30, 22	$6.64B	+71.9%	+175.8%	+175.8%	+175.8%
TTM Net Income	Sep 30, 22	$5.26B	+65.2%	+161.8%	+161.8%	+161.8%

TTM EBITDA Highs

SNY TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$10.83B	N/A	at high
3Y	$10.83B	N/A	at high
5Y	$10.83B	Sep 30, 22	at high
All	$10.83B	Sep 30, 22	at high

TTM EBITDA Lows

SNY TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$10.83B	N/A	at low
3Y	$10.83B	N/A	at low
5Y	$3.03B	Mar 31, 22	+257.3%
All	-$18.24B	Dec 31, 07	+159.4%

TTM EBITDA History

Month	Value	Change
Sep 2022	$10.83B	+91.1%
Jun 2022	$5.67B	+87.0%
Mar 2022	$3.03B	-30.7%
Mar 2015	$4.37B	+89.9%
Dec 2014	$2.30B	-71.9%
Dec 2013	$8.20B	+35.0%
Sep 2013	$6.07B	-1.3%
Mar 2013	$6.16B	+93.5%
Jun 2012	$3.18B	-19.3%
Jun 2011	$3.94B	+70.3%
Dec 2010	$2.31B	-65.5%
Dec 2009	$6.72B	+86.1%
Jun 2009	$3.61B	-18.9%
Dec 2008	$4.45B	+124.8%
Jun 2008	-$17.91B	+1.8%
Dec 2007	-$18.24B	-5.4%
Jun 2007	-$17.30B	-34.6%
Dec 2006	-$12.85B	-227.2%

Month	Value	Change
Jun 2006	$10.10B	-3.7%
Mar 2006	$10.49B	+0.0%
Dec 2005	$10.49B	+77.6%
Sep 2005	$5.91B	-14.1%
Jun 2005	$6.88B	+42.8%
Mar 2005	$4.82B	+109.2%
Dec 2004	$2.30B	-64.4%
Sep 2004	$6.46B	+143.0%
Jun 2004	$2.66B	+5.2%
Mar 2004	$2.53B	+37.9%
Dec 2003	$1.83B	-31.7%
Sep 2003	$2.68B	+48.9%
Jun 2003	$1.80B	+15.1%
Mar 2003	$1.56B	+399.1%
Dec 2002	-$523.07M	-121.5%
Sep 2002	$2.43B	+310.2%
Jun 2002	$593.09M	-

FAQ

What is the current TTM EBITDA of SNY?
As of today, SNY TTM EBITDA is $10.83B
What is SNY TTM EBITDA most recent change?
SNY TTM EBITDA was up +91.09% on September 30, 2022
What is 1-year change in SNY TTM EBITDA?
SNY TTM EBITDA is up +257.29% year-over-year
How far is SNY TTM EBITDA from its all-time high?
SNY TTM EBITDA is currently at its all-time high
How does SNY TTM EBITDA rank versus sector peers?
SNY TTM EBITDA is higher than 98.45% of companies in Healthcare sector
When is SNY next earnings release?
The next earnings release for SNY is on April 23, 2026

EBITDA Formula

EBITDA = Net Income + Interest Expense + Income Tax + Depreciation & Amortization

Data Sources & References

SNY Official Website www.sanofi.com
SNY Profile on Yahoo Finance finance.yahoo.com/quote/SNY
SNY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sny